ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 102 filers reported holding ANACOR PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $16,729,000 | -50.3% | 312,998 | +5.1% | 0.01% | -52.6% |
| Q4 2015 | $33,637,000 | -4.3% | 297,755 | -0.3% | 0.02% | -9.5% |
| Q3 2015 | $35,158,000 | +52.2% | 298,692 | +0.1% | 0.02% | +61.5% |
| Q2 2015 | $23,094,000 | +39.3% | 298,271 | +4.1% | 0.01% | +44.4% |
| Q1 2015 | $16,576,000 | +94.4% | 286,550 | +8.4% | 0.01% | +80.0% |
| Q4 2014 | $8,527,000 | +53.8% | 264,443 | +16.7% | 0.01% | +25.0% |
| Q3 2014 | $5,545,000 | +85.5% | 226,615 | +34.4% | 0.00% | +100.0% |
| Q2 2014 | $2,990,000 | -7.9% | 168,654 | +3.9% | 0.00% | 0.0% |
| Q1 2014 | $3,247,000 | +21.3% | 162,323 | +1.8% | 0.00% | 0.0% |
| Q4 2013 | $2,676,000 | +90.1% | 159,516 | +20.3% | 0.00% | +100.0% |
| Q3 2013 | $1,408,000 | +99.4% | 132,598 | +5.0% | 0.00% | 0.0% |
| Q2 2013 | $706,000 | – | 126,249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |